(Q35709197)

9 August 2017

1 reference

title

Population and evolutionary dynamics of phage therapy (English)

1 reference

9 August 2017

1 reference

Evolutionary dynamics

1 reference

Bruce R Levin

1

1 reference

PubMed ID

15040264

9 August 2017

James J Bull

series ordinal

2

1 reference

PubMed ID

15040264

9 August 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

Nature Reviews Microbiology

9 August 2017

1 reference

9 August 2017

2

1 reference

9 August 2017

166-173

1 reference

9 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro822

9 August 2017

0 references

cites work

Bacteriophage Therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

21 January 2018

Bacteriophage therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

The prospect for bacteriophage therapy in Western medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Adventures with antibacterial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Passive immunity in prevention and treatment of infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Long-circulating bacteriophage as antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Phage therapy: the peculiar kinetics of self-replicating pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Understanding bacteriophage therapy as a density-dependent kinetic process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Overcoming the phage replication threshold: a mathematical model with implications for phage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

The future of bacteriophage biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Prevention of Escherichia coli infection in broiler chickens with a bacteriophage aerosol spray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Bacteriophage therapy of infectious diseases in aquaculture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Dynamics of success and failure in phage and antibiotic therapy in experimental infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Linking genetic change to community evolution: insights from studies of bacteria and bacteriophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Trade-offs and coexistence in microbial microcosms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Antagonistic coevolution between a bacterium and a bacteriophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Reducing antibiotic resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

AN INVESTIGATION ON THE NATURE OF ULTRA-MICROSCOPIC VIRUSES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Bacteriophages show promise as antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Bacteriophages as therapeutic agents.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Treatment of experimental infections of mice with bacteriophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Bacteriophage control of Pseudomonas plecoglossicida infection in ayu Plecoglossus altivelis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Pharmacokinetic principles of bacteriophage therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Examination of bacteriophage as a biocontrol method for salmonella on fresh-cut fruit: a model study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Phenotypic tolerance: the search for beta-lactam antibiotics that kill nongrowing bacteria

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRMICRO822

31 March 2020

https://api.crossref.org/works/10.1038%2FNRMICRO822

inferred from DOI database lookup

7 January 2021

based on heuristic

Constraints on the Coevolution of Bacteria and Virulent Phage: A Model, Some Experiments, and Predictions for Natural Communities

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

Adaptation to the fitness costs of antibiotic resistance in Escherichia coli

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

The cost of antibiotic resistance from a bacterial perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

THE MULTIPLICATION OF BACTERIOPHAGE IN VIVO AND ITS PROTECTIVE EFFECT AGAINST AN EXPERIMENTAL INFECTION WITH SHIGELLA DYSENTERIAE.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO822

31 March 2020

Identifiers

DOI

10.1038/NRMICRO822

1 reference

9 August 2017

1 reference

PubMed ID

15040264